Silver Cross Hospital

Patient Safety - All

Healthcare-Associated Infections

Hospitals in Illinois are participating in programs to reduce the number of infections acquired during hospital stays. While it is difficult to reduce infections to zero, following specific protocols can greatly reduce the risk.

The Hospital Report Card Act (Illinois Public Act 93-563) requires Illinois hospitals to report central line associated bloodstream infections (CLABSIs) as well as surgical site infections (SSIs). As of January 1, 2012, hospitals are also mandated to report Methicillin-resistant Staphylococcus aureus (MRSA) bloodstream infections and Clostridioides difficileinfections. Infections are reported through the CDC’s National Healthcare Safety Network (NHSN) surveillance system. The Standardized Infection Ratio (SIR), a summary measure used to determine whether infection data are statistically different from the national average, is presented for each type of infection shown below. Read more about healthcare-associated infections in Illinois. To learn more about the data collection methods using the CDC's National Health Safety Network (NHSN) surveillance system, read the Report Card methodology.

Clostridioides difficile infections (CDI) and Methicillin-resistant Staphylococcus aureus (MRSA) bloodstream infections

Facility-wide Healthcare Facility Onset Incidence Rates for CDI and MRSA are presented below. These rates are based on results of laboratory tests that were obtained on or after day four of an inpatient stay and do not consider presence or timing of clinical signs or symptoms. The Standardized Infection Ratio (SIR) is presented, which is a summary measure used to determine if rates of CDI and MRSA bloodstream infections are statistically different from the national average. Statewide summaries of CDI and MRSA data arranged by hospital are also included. Note: Starting with 2016 data, new methods for risk adjustment were used.

Statistical Significance

Statistically significantly better than state average or performing at the best possible rate

Not statistically significantly better or worse than state average

Statistically significantly worse than state average

Footnotes

Key	Description
38	Exempt: No Licensed PICU Beds
39	Exempt: No Licensed NICU Beds
46	Complete Reporting: Zero infections. Number of reported events is not significantly different than predicted
47	Complete Reporting: Number of predicted LabID events too low to calculate a precise SIR
48	No Target Procedures Performed
117	Complete Reporting: Zero infections. Number of reported events is not significantly different than predicted
153	Complete Reporting: Zero infections. Number of predicted events too low to calculate a precise SIR
169	Exempt: No Licensed ICU Beds

Central Line Associated Bloodstream Infections (CLABSIs)

Presented below are annual central line-associated bloodstream infections (CLABSIs) occurring in critical care units, also known as intensive care units (ICUs). ICU-specific summary data for CLABSI are provided using the Standardized Infection Ratio(SIR). Statewide summaries of CLABSI data arranged by ICU type and hospital are also included.

Statistical Significance

Statistically significantly better than state average or performing at the best possible rate

Not statistically significantly better or worse than state average

Statistically significantly worse than state average

Footnotes

Key	Description
38	Exempt: No Licensed PICU Beds
39	Exempt: No Licensed NICU Beds
46	Complete Reporting: Zero infections. Number of reported events is not significantly different than predicted
47	Complete Reporting: Number of predicted LabID events too low to calculate a precise SIR
48	No Target Procedures Performed
117	Complete Reporting: Zero infections. Number of reported events is not significantly different than predicted
153	Complete Reporting: Zero infections. Number of predicted events too low to calculate a precise SIR
169	Exempt: No Licensed ICU Beds

Adult CLABSI

Adult CLABSI Measure	Result	SIR
Adult Medical/Surgical ICU Q1 2019 - Q4 2019 Result 0 infections, 2419 central-line days ¹¹⁷ Rating SIR: 0.00 ¹¹⁷	0 infections, 2419 central-line days ¹¹⁷	0.00 ¹¹⁷
Description Central Line-associated Bloodstream Infection data in the Adult Medical/Surgical ICU summarized as a Standardized Infection Ratio. Historical Data
Measure	Result	Rating
Q1 2018 - Q4 2018 Result 3 infections, 2171 central-line days Rating SIR: 1.59	3 infections, 2171 central-line days	1.59
Q1 2017 - Q4 2017 Result 3 infections, 1980 central-line days Rating SIR: 1.75	3 infections, 1980 central-line days	1.75
Q1 2016 - Q4 2016 Result 2 infections, 2384 central-line days Rating SIR: 0.97	2 infections, 2384 central-line days	0.97
Q1 2015 - Q4 2015 Result 1 infections, 1742 central-line days Rating SIR: 0.38	1 infections, 1742 central-line days	0.38
Q1 2014 - Q4 2014 Result 0 infections, 1703 central-line days ¹¹⁷ Rating SIR: 0.00 ¹¹⁷	0 infections, 1703 central-line days ¹¹⁷	0.00 ¹¹⁷
Q1 2013 - Q4 2013 Result 7 infections, 2616 central-line days Rating SIR: 1.78	7 infections, 2616 central-line days	1.78
Q1 2012 - Q4 2012 Result 5 infections, 2083 central-line days Rating SIR: 2.67	5 infections, 2083 central-line days	2.67
Q1 2011 - Q4 2011 Result 3 infections, 1592 central-line days Rating SIR: 1.26	3 infections, 1592 central-line days	1.26
Q1 2010 - Q4 2010 Result 2 infections, 1550 central-line days Rating SIR: 0.86	2 infections, 1550 central-line days	0.86

Pediatric CLABSI

Ped. CLABSI Measure	Result	SIR
Pediatric Medical-Surgical ICU Q1 2019 - Q4 2019 Result N/A infections, N/A central-line days ¹⁶⁹ Rating SIR: N/A ¹⁶⁹	N/A infections, N/A central-line days ¹⁶⁹	N/A ¹⁶⁹
Description Central Line-associated Bloodstream Infection (CLABSI) data in the Medical-Surgical Pediatric ICU summarized as a Standardized Infection Ratio. Historical Data
Measure	Result	Rating
Q1 2018 - Q4 2018 Result N/A infections, N/A central-line days ¹⁶⁹ Rating SIR: N/A ¹⁶⁹	N/A infections, N/A central-line days ¹⁶⁹	N/A ¹⁶⁹
Q1 2017 - Q4 2017 Result N/A infections, N/A central-line days ¹⁶⁹ Rating SIR: N/A ¹⁶⁹	N/A infections, N/A central-line days ¹⁶⁹	N/A ¹⁶⁹
Q1 2016 - Q4 2016 Result N/A infections, N/A central-line days ³⁸ Rating SIR: N/A ³⁸	N/A infections, N/A central-line days ³⁸	N/A ³⁸
Q1 2015 - Q4 2015 Result N/A infections, N/A central-line days ³⁸ Rating SIR: N/A ³⁸	N/A infections, N/A central-line days ³⁸	N/A ³⁸
Q1 2014 - Q4 2014 Result N/A infections, N/A central-line days ³⁸ Rating SIR: N/A ³⁸	N/A infections, N/A central-line days ³⁸	N/A ³⁸
Q1 2013 - Q4 2013 Result N/A infections, N/A central-line days ³⁸ Rating SIR: N/A ³⁸	N/A infections, N/A central-line days ³⁸	N/A ³⁸
Q1 2012 - Q4 2012 Result N/A infections, N/A central-line days ³⁸ Rating SIR: N/A ³⁸	N/A infections, N/A central-line days ³⁸	N/A ³⁸
Q1 2011 - Q4 2011 Result N/A infections, N/A central-line days ³⁸ Rating SIR: N/A ³⁸	N/A infections, N/A central-line days ³⁸	N/A ³⁸
Q1 2010 - Q4 2010 Result N/A infections, N/A central-line days ³⁸ Rating SIR: N/A ³⁸	N/A infections, N/A central-line days ³⁸	N/A ³⁸
Q1 2010 - Q2 2010 Result N/A infections, N/A central-line days Rating SIR: 0.00	N/A infections, N/A central-line days	0.00

NICU CLABSI

NICU CLABSI Measure	Result	SIR
Level III Neonatal ICU Q1 2019 - Q4 2019 Result N/A infections, N/A central-line days ¹⁶⁹ Rating SIR: N/A ¹⁶⁹	N/A infections, N/A central-line days ¹⁶⁹	N/A ¹⁶⁹
Description Central Line-associated Bloodstream Infection data in the Level III Neonatal ICU summarized as a Standardized Infection Ratio. Historical Data
Measure	Result	Rating
Q1 2018 - Q4 2018 Result N/A infections, N/A central-line days ¹⁶⁹ Rating SIR: N/A ¹⁶⁹	N/A infections, N/A central-line days ¹⁶⁹	N/A ¹⁶⁹
Q1 2017 - Q4 2017 Result N/A infections, N/A central-line days ¹⁶⁹ Rating SIR: N/A ¹⁶⁹	N/A infections, N/A central-line days ¹⁶⁹	N/A ¹⁶⁹
Q1 2016 - Q4 2016 Result N/A infections, N/A central-line days ³⁹ Rating SIR: N/A ³⁹	N/A infections, N/A central-line days ³⁹	N/A ³⁹
Q1 2015 - Q4 2015 Result N/A infections, N/A central-line days ³⁹ Rating SIR: N/A ³⁹	N/A infections, N/A central-line days ³⁹	N/A ³⁹
Q1 2014 - Q4 2014 Result N/A infections, N/A central-line days ³⁹ Rating SIR: N/A ³⁹	N/A infections, N/A central-line days ³⁹	N/A ³⁹
Q1 2013 - Q4 2013 Result N/A infections, N/A central-line days ³⁹ Rating SIR: N/A ³⁹	N/A infections, N/A central-line days ³⁹	N/A ³⁹
Q1 2012 - Q4 2012 Result N/A infections, N/A central-line days ³⁹ Rating SIR: N/A ³⁹	N/A infections, N/A central-line days ³⁹	N/A ³⁹
Q1 2011 - Q4 2011 Result N/A infections, N/A central-line days ³⁹ Rating SIR: N/A ³⁹	N/A infections, N/A central-line days ³⁹	N/A ³⁹
Q1 2010 - Q4 2010 Result N/A infections, N/A central-line days ³⁹ Rating SIR: N/A ³⁹	N/A infections, N/A central-line days ³⁹	N/A ³⁹
Q1 2010 - Q2 2010 Result N/A infections, N/A central-line days Rating SIR: N/A	N/A infections, N/A central-line days	N/A

Surgical Site Infections (SSIs)

Presented below are data for surgical site infections associated with coronary artery bypass graft surgery (CABG) and total knee replacement surgery (KPROs) using the Standardized Infection Ratio (SIR). Superficial and secondary surgical site infections are not included in the summary data below. Statewide summaries of surgical site infection data arranged by surgical procedure (CABG, KPRO) and hospital are also included.

Statistical Significance

Statistically significantly better than state average or performing at the best possible rate

Not statistically significantly better or worse than state average

Statistically significantly worse than state average

Footnotes

Key	Description
38	Exempt: No Licensed PICU Beds
39	Exempt: No Licensed NICU Beds
46	Complete Reporting: Zero infections. Number of reported events is not significantly different than predicted
47	Complete Reporting: Number of predicted LabID events too low to calculate a precise SIR
48	No Target Procedures Performed
117	Complete Reporting: Zero infections. Number of reported events is not significantly different than predicted
153	Complete Reporting: Zero infections. Number of predicted events too low to calculate a precise SIR
169	Exempt: No Licensed ICU Beds

Immunization Practices

Illinois hospitals are focusing their efforts on boosting immunization treatments and strengthening patient safety protocols. The objective is not merely achieving statistical success, but also enhancing the quality of care and patient well-being.

Data on immunization measures in Illinois hospitals is available through the Medicare comparison tool at medicare.gov/hospitalcompare. This tool provides valuable insights, allowing patients and their families to gauge the quality of care and safety practices at local hospitals, helping them make informed healthcare decisions.

In the realm of Patient Safety, a host of measures are assessed, with risk-adjusted rates available for each. These measures encompass various aspects of patient care and treatment outcomes. However, interpreting these metrics requires an understanding of the complexity and context-specific nature of healthcare.

Immunization

These indicators are used to measure immunization treatments at hospitals. This data comes from medicare.gov/hospitalcompare.

Measure	Result
Healthcare workers given influenza vaccination Q4 2017 - Q1 2018 Result 91.00 %	91.00 %
Description Influenza Vaccination Coverage among Healthcare Personnel

Measure

Healthcare workers given influenza vaccination

Q4 2017 - Q1 2018

Result: 91.00 %

Illinois Hospital Report Card

and Consumer Guide to Health Care

Silver Cross Hospital

Patient Safety - All

Healthcare-Associated Infections

Clostridioides difficile infections (CDI) and Methicillin-resistant Staphylococcus aureus (MRSA) bloodstream infections

Statistical Significance

Footnotes

Description

Historical Data

Description

Historical Data

Central Line Associated Bloodstream Infections (CLABSIs)

Statistical Significance

Footnotes

Adult CLABSI

Description

Historical Data

Pediatric CLABSI

Description

Historical Data

NICU CLABSI

Description

Historical Data

Surgical Site Infections (SSIs)

Statistical Significance

Footnotes

Description

Historical Data

Description

Historical Data

Immunization Practices

Immunization

Description

Healthcare Facility Onset Incidence Rate	Result	SIR
Methicillin-resistant Staphylococcus aureus (MRSA) blood stream infections Q1 2019 - Q4 2019 Result 0 infections, 90078 patient days Rating SIR: 0.00	0 infections, 90078 patient days	0.00
Description Methicillin-resistant Staphylococcus aureus infections summarized as a Standardized Infection Ratio Historical Data
Measure	Result	Rating
Q1 2018 - Q4 2018 Result 2 infections, 76231 patient days Rating SIR: 0.76	2 infections, 76231 patient days	0.76
Q1 2017 - Q4 2017 Result 1 infections, 74094 patient days Rating SIR: 0.33	1 infections, 74094 patient days	0.33
Q1 2016 - Q4 2016 Result 3 infections, 76677 patient days Rating SIR: 1.13	3 infections, 76677 patient days	1.13
Q1 2015 - Q4 2015 Result 3 infections, 71079 patient days Rating SIR: 1.02	3 infections, 71079 patient days	1.02
Q1 2014 - Q4 2014 Result 1 infections, 81985 patient days Rating SIR: 0.30	1 infections, 81985 patient days	0.30
Q1 2013 - Q4 2013 Result 2 infections, 79456 patient days Rating SIR: 0.61	2 infections, 79456 patient days	0.61
Q1 2012 - Q4 2012 Result 3 infections, 129456 patient days Rating SIR: 0.53	3 infections, 129456 patient days	0.53
Q1 2012 - Q2 2012 Result 2 infections, 33585 patient days Rating SIR: 0.60	2 infections, 33585 patient days	0.60
Clostridioides difficile infections (CDI) Q1 2019 - Q4 2019 Result 16 infections, 82599 patient days Rating SIR: 0.25	16 infections, 82599 patient days	0.25
Description Clostridium difficile infections summarized as a Standardized Infection Ratio Historical Data
Measure	Result	Rating
Q1 2018 - Q4 2018 Result 11 infections, 69296 patient days Rating SIR: 0.28	11 infections, 69296 patient days	0.28
Q1 2017 - Q4 2017 Result 32 infections, 66970 patient days Rating SIR: 0.70	32 infections, 66970 patient days	0.70
Q1 2016 - Q4 2016 Result 35 infections, 69035 patient days Rating SIR: 0.71	35 infections, 69035 patient days	0.71
Q1 2015 - Q4 2015 Result 40 infections, 64100 patient days Rating SIR: 0.76	40 infections, 64100 patient days	0.76
Q1 2014 - Q4 2014 Result 34 infections, 75510 patient days Rating SIR: 0.56	34 infections, 75510 patient days	0.56
Q1 2013 - Q4 2013 Result 37 infections, 73103 patient days Rating SIR: 0.65	37 infections, 73103 patient days	0.65
Q1 2012 - Q4 2012 Result 36 infections, 66201 patient days Rating SIR: 0.71	36 infections, 66201 patient days	0.71

SSI Measure	Result	SIR
Total Knee Replacement Surgery Q1 2019 - Q4 2019 Result 2 infections, 520 procedures Rating SIR: 1.04	2 infections, 520 procedures	1.04
Description Surgical Site Infections Associated with Total Knee Replacement Surgery Summarized as a Standardized Infection Ratio Historical Data
Measure	Result	Rating
Q1 2018 - Q4 2018 Result 1 infections, 473 procedures Rating SIR: 0.58	1 infections, 473 procedures	0.58
Q1 2017 - Q4 2017 Result 4 infections, 348 procedures Rating SIR: 3.12	4 infections, 348 procedures	3.12
Q1 2016 - Q4 2016 Result 2 infections, 421 procedures Rating SIR: 1.28	2 infections, 421 procedures	1.28
Q1 2015 - Q4 2015 Result 1 infections, 328 procedures Rating SIR: 0.53	1 infections, 328 procedures	0.53
Q3 2013 - Q2 2014 Result 0 infections, 243 procedures ¹¹⁷ Rating SIR: 0.00 ¹¹⁷	0 infections, 243 procedures ¹¹⁷	0.00 ¹¹⁷
Q3 2012 - Q2 2013 Result 0 infections, 243 procedures ¹¹⁷ Rating SIR: 0.00 ¹¹⁷	0 infections, 243 procedures ¹¹⁷	0.00 ¹¹⁷
Q3 2011 - Q2 2012 Result 0 infections, 262 procedures ⁴⁶ Rating SIR: 0.00 ⁴⁶	0 infections, 262 procedures ⁴⁶	0.00 ⁴⁶
Q3 2010 - Q2 2011 Result 1 infections, 174 procedures ⁴⁷ Rating SIR: N/A ⁴⁷	1 infections, 174 procedures ⁴⁷	N/A ⁴⁷
Coronary Artery Bypass Graft Surgery Q1 2019 - Q4 2019 Result 0 infections, 78 procedures ¹⁵³ Rating SIR: N/A ¹⁵³	0 infections, 78 procedures ¹⁵³	N/A ¹⁵³
Description Surgical Site Infections Associated with Coronary Artery Bypass Graft Surgery Summarized as a Standardized Infection Ratio Historical Data
Measure	Result	Rating
Q1 2018 - Q4 2018 Result N/A infections, N/A procedures ⁴⁸ Rating SIR: N/A ⁴⁸	N/A infections, N/A procedures ⁴⁸	N/A ⁴⁸
Q1 2016 - Q4 2016 Result N/A infections, N/A procedures ⁴⁸ Rating SIR: N/A ⁴⁸	N/A infections, N/A procedures ⁴⁸	N/A ⁴⁸
Q1 2015 - Q4 2015 Result N/A infections, N/A procedures ⁴⁸ Rating SIR: N/A ⁴⁸	N/A infections, N/A procedures ⁴⁸	N/A ⁴⁸
Q3 2013 - Q2 2014 Result N/A infections, N/A procedures ⁴⁸ Rating SIR: N/A ⁴⁸	N/A infections, N/A procedures ⁴⁸	N/A ⁴⁸
Q3 2012 - Q2 2013 Result N/A infections, N/A procedures ⁴⁸ Rating SIR: N/A ⁴⁸	N/A infections, N/A procedures ⁴⁸	N/A ⁴⁸
Q3 2011 - Q2 2012 Result N/A infections, N/A procedures ⁴⁸ Rating SIR: N/A ⁴⁸	N/A infections, N/A procedures ⁴⁸	N/A ⁴⁸
Q3 2010 - Q2 2011 Result N/A infections, N/A procedures ⁴⁸ Rating SIR: N/A ⁴⁸	N/A infections, N/A procedures ⁴⁸	N/A ⁴⁸